
Prof Michael Stark
Michael Stark specializes in Obstetrics and Gynecology. His main interest is gynecological oncology. He
initiated the VIEZION project which combines targeted chemotherapy, PIF, immunology and stem-cell
therapy for improving post-surgical oncological treatment.
He is currently a scientist at the Charité University Hospital in Berlin, and since 2004 he is the President of
the New European Surgical Academy (NESA), an international inter-disciplinary surgical organization with
members in 62 countries with a formal cooperation with FIGO concerning transmission of surgical
knowledge to countries with limited resources.
In 2011, Prof. Stark was nominated as the Medico Del Anno (Doctor of the Year) in Italy, and is an
Honorary Member of the French, Polish, Russian, Austrian-Serbian, and Italian Gynecological
Associations.
In the years 1983-2000 he was the medical director and head of Ob/Gyn department of the Misgav
Ladach General Hospital in Jerusalem, and between 2001 and 2009 the chairman of all Ob/Gyn
departments of the HELIOS Hospital Group in Europe. He was the scientific director of the European
novel Tele-surgical system. He was visiting Professor at the Universities of Toronto, Moscow, Beijing,
Milan, Adana, Uppsala and the Weill-Cornell University hospital in New York.
He modified operations like the vaginal and abdominal hysterectomy and Cesarean Section and
developed the concept of single-entry natural orifice surgery. He was involved in the development of the
trans-oral thyroidectomy and TransDouglas abdominal surgery. He initiated the AI working group in
surgery